GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia

Molecular Psychiatry

Volumn 16, Issue 11, 2011, Pages 1117-1129

  Chen, X ^a,b   Lee, G ^a   Maher, B S ^a   Fanous, A H ^a,c,d   Chen, J ^a   Zhao, Z ^e   Guo, A ^e   Van Den Oord, E ^a,b   Sullivan, Patrick ^f   Shi, J ^g   Levinson, D F ^g   Gejman, P V ^h   Sanders, A ^h   Duan, J ^h   Owen, M J ⁱ   Craddock, Nick J ^an   O'Donovan, Michael C ^i,an   Blackman, J ⁱ   Lewis, D ⁱ   Kirov, George K ^an   Qin, W ^j   Schwab, S ^j   Wildenauer, D ^j   Chowdari, K ^k   Nimgaonkar, V ^k   Straub, R E ^l   Weinberger, D R ^l   O'Neill, F A ^m   Walsh, D ⁿ   Bronstein, M ^o   Darvasi, A ^o   Lencz, T ^p   Malhotra, A K ^p   Rujescu, D ^q   Giegling, I ^q   Werge, T ^r   Hansen, T ^r   Ingason, A ^r   Noethen M M ^s   Rietschel, M ^s,t   Cichon, S ^s,u   Djurovic, S ^v   Andreassen, O A ^v   Cantor, R M ^w   Ophoff, R ^w,x   Corvin, Aiden ^y   Morris, Derek W ^y   Gill, Michael ^y   Pato, Carlos N ^z   Pato, Michele T ^z   Macedo, Antonio ^aa   Gurling, H M D ^ab   McQuillin, Andrew ^ab   Pimm, Jonathan ^ab   Hultman, C ^ac   Lichtenstein, Paul ^ac   Sklar, Pamela ^ae,al   Purcell, Shaun M ^ae,al   Scolnick, E ^ad,ae   St Clair, David ^af   Blackwood, Douglas H R ^ag   Kendler, K S ^a,b   Kahn, René S ^ah   Linszen, Don H ^ai   Van Os, Jim ^aj   Wiersma, Durk ^ak   Bruggeman, Richard ^ak   Cahn, Wiepke ^ah   De Haan, Lieuwe ^ai   Krabbendam, Lydia ^aj   Myin Germeys, Inez ^aj   Holmans, Peter A ^an   Williams, Nigel M ^an   Georgieva, Lyudmila ^an   Nikolov, Ivan ^an   Norton, N ^an   Williams, H ^an   Toncheva, Draga ^aq   Milanova, Vihra ^aq   Hultman, Christina M ^ac,ao   Thelander, Emma F ^ac   O'Dushlaine, Colm T ^y   Kenny, Elaine ^y   Quinn, Emma M ^y   Choudhury, Khalid ^ab   Datta, Susmita ^ab   Thirumalai, Srinivasa ^ar   Puri, Vinay ^ab   Krasucki, Robert ^ab   Lawrence, Jacob ^ab   Quested, Digby ^as   Bass, Nicholas ^ab   Gurling, Hugh ^ab   Crombie, Caroline ^ap   Fraser, Gillian ^ap   Kuan, Soh Leh ^af   Walker, Nicholas ^at   Muir, Walter J ^ag   McGhee, Kevin A ^ag   Pickard, Ben ^ag   Malloy, Pat ^ag   Maclean, Alan W ^ag   Van Beck, Margaret ^ag   Wray, Naomi R ^am   Macgregor, Stuart ^am   Visscher, Peter M ^am   Medeiros, Helena ^z   Middleton, Frank ^au   Carvalho, Celia ^z   Morley, Christopher ^au   Fanous, Ayman ^a,c,d,z   Conti, David ^z   Knowles, James A ^z   Ferreira, Carlos Paz ^av   Azevedo, M Helena ^aa   Stone, Jennifer L ^ae,al   Ruderfer, Douglas M ^ae,al   Kirby, Andrew N ^ae,al   Ferreira, Manuel A R ^ae,al   Daly, Mark J ^ae,al   Chambert, Kimberly ^al   Kuruvilla, Finny ^al   Gabriel, Stacey B ^al   Ardlie, Kristin ^al   Moran, Jennifer L ^al   Scolnick, Edward M ^al   more..

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g STANFORD UNIVERSITY   (United States)

^h NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

ⁱ CARDIFF UNIVERSITY   (United Kingdom)

^j UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^k UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^l NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^m QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

ⁿ HEALTH RESEARCH BOARD   (Ireland)

^o HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^p ZUCKER HILLSIDE HOSPITAL   (United States)

^q UNIVERSITY OF MUNICH   (Germany)

^r Mental Health Services CPH   (Denmark)

^s UNIVERSITY OF BONN   (Germany)

^t UNIVERSITY OF HEIDELBERG   (Germany)

^u FORSCHUNGSZENTRUM JÜLICH   (Germany)

^v UNIVERSITY OF OSLO   (Norway)

^w UNIVERSITY OF CALIFORNIA   (United States)

^x UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^y TRINITY COLLEGE DUBLIN   (Ireland)

^z UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^aa UNIVERSITY OF COIMBRA   (Portugal)

^ab ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^ac KAROLINSKA INSTITUTE   (Sweden)

^ad Psychiatric and Neurodevelopmental Genetics Unit   (United States)

^ae MASSACHUSETTS GENERAL HOSPITAL   (United States)

^af UNIVERSITY OF ABERDEEN   (United Kingdom)

^ag UNIVERSITY OF EDINBURGH   (United Kingdom)

^ah UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ai UNIVERSITY OF AMSTERDAM   (Netherlands)

^aj MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^ak UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^al MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^am QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^an CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^ao UPPSALA UNIVERSITY   (Sweden)

^ap UNIVERSITY OF ABERDEEN   (United Kingdom)

^aq UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^ar West Berkshire NHS Trust   (United Kingdom)

^as WARNEFORD HOSPITAL   (United Kingdom)

^at Ravenscraig Hospital   (United Kingdom)

^au SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^av NONE   (Portugal)

more..

Author keywords

association study; cardiomyopathy; GWA data mining; meta analysis; schizophrenia

Indexed keywords

CARDIOMYOPATHY ASSOCIATED 5 PROTEIN; COLQ PROTEIN; CYSTEINE RICH TRANSMEMBRANE BMP REGULATOR 1; DNA CROSS LINK REPAIR 1C PROTEIN; DYSBINDIN; ECHINODERM MICROTUBULE ASSOCIATED PROTEIN LIKE 5; EML5 PROTEIN; GLI FAMILY ZINC FINGER 1 PROTEIN; IONOTROPIC RECEPTOR DELTA 1; LOW DENSITY LIPOPROTEIN RELATED PROTEIN 1; LOW DENSITY LIPOPROTEIN RELATED PROTEIN 1B; LOW DENSITY LIPOPROTEIN RELATED PROTEIN 8; NEURONAL NITRIC OXIDE SYNTHASE ADAPTOR PROTEIN; NEUROTROPHIC TYROSINE KINASE RECEPTOR TYPE 3; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 21; NTRK3 PROTEIN; NUCLEAR TRANSPORT FACTOR 2; NUTF2 PROTEIN; PROTEIN; PTPN21 PROTEIN; SERINE INCORPORATOR 1 PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN 592;

ARTICLE; BIOINFORMATICS; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DATA MINING; EXON; FAMILY; GENE FREQUENCY; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; PRIORITY JOURNAL; REPLICATION STUDY; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79958143783     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2010.96     Document Type: Article

References (54)

1. Sullivan PF, Lin D, Tzeng JY, van den OE, Perkins D, Stroup TS et al. Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry 2008; 13: 570-584. (Pubitemid 351704941)
2. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009; 460: 753-757.
3. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748-752.
4. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D et al. Common variants conferring risk of schizophrenia. Nature 2009; 460: 744-747.
5. Lencz T, Morgan TV, Athanasiou M, Dain B, Reed CR, Kane CR et al. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry 2007; 12: 572-580. (Pubitemid 46816774)
6. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 2008; 40: 1053-1055.
7. O'Donovan MC, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I et al. Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2. Mol Psychiatry 2009; 14: 30-36.
8. Ingason A, Giegling I, Cichon S, Hansen T, Rasmussen HB, Nielsen J et al. A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia. Hum Mol Genet 2010; 19: 1379-1386.
9. Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 1999; 14: 143-149. (Pubitemid 29095371)
10. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575. (Pubitemid 47330214)
11. Sun J, Jia P, Fanous AH, Webb BT, van den Oord EJ, Chen X et al. A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case. Bioinformatics 2009; 25: 2595-6602.
12. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265. (Pubitemid 40202029)
13. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 2008; 66: 87-98. (Pubitemid 351482562)
14. Martin ER, Monks SA, Warren LL, Kaplan NL. A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 2000; 67: 146-154. (Pubitemid 30481552)
15. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
16. Shyn SI, Shi J, Kraft JB, Potash JB, Knowles JA, Weissman MM et al. Novel loci for major depression identified by genome-wide association study of sequenced treatment alternatives to relieve depression and meta-analysis of three studies. Mol Psychiatry 2010 (in press).
17. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575. (Pubitemid 47330214)
18. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002; 71: 337-348. (Pubitemid 34800250)
19. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007; 316: 1341-1345. (Pubitemid 46871655)
20. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 445: 881-885.
21. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007; 316: 1336-1341. (Pubitemid 46871654)
22. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008; 40: 616-622. (Pubitemid 351601203)
23. Spitz MR, Amos CI, Dong Q, Lin J, Wu X. The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst 2008; 100: 1552-1556.
24. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008; 452: 638-642. (Pubitemid 351483366)
25. Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009; 41: 1303-1307.
26. Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009; 41: 1308-1312.
27. Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, Burtt NP et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008; 40: 1216-1223.
28. Graham RR, Cotsapas C, Davies L, Hackett R, Lessard CJ, Leon JM et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 2008; 40: 1059-1061.
29. Benson MA, Tinsley CL, Blake DJ. Myospryn is a novel binding partner for dysbindin in muscle. J Biol Chem 2004; 279: 10450-10458. (Pubitemid 38372654)
30. Reynolds JG, McCalmon SA, Tomczyk T, Naya FJ. Identification and mapping of protein kinase A binding sites in the costameric protein myospryn. Biochim Biophys Acta 2007; 1773: 891-902.
31. Sarparanta J. Biology of myospryn: what's known? J Muscle Res Cell Motil 2008; 29: 177-180.
32. Nakagami H, Kikuchi Y, Katsuya T, Morishita R, Akasaka H, Saitoh S et al. Gene polymorphism of myospryn (cardiomyopathy-associated 5) is associated with left ventricular wall thickness in patients with hypertension. Hypertens Res 2007; 30: 1239-1246. (Pubitemid 351176422)
33. Talbot K, Cho DS, Ong WY, Benson MA, Han LY, Kazi HA et al. Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin. Hum Mol Genet 2006; 15: 3041-3054. (Pubitemid 44530708)
34. Kouloumenta A, Mavroidis M, Capetanaki Y. Proper perinuclear localization of the TRIM-like protein myospryn requires its binding partner desmin. J Biol Chem 2007; 282: 35211-35221. (Pubitemid 350232467)
35. Owen MJ, Williams NM, O'Donovan MC. Dysbindin-1 and schizophrenia: from genetics to neuropathology. J Clin Invest 2004; 113: 1255-1257.
36. Williams NM, O'Donovan MC, Owen MJ. Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia? Schizophr Bull 2005; 31: 800-805. (Pubitemid 41437772)
37. Duan J, Martinez M, Sanders AR, Hou C, Burrell GJ, Krasner AJ et al. DTNBP1 (Dystrobrevin Binding Protein 1) and schizophrenia: association evidence in the 30 end of the gene. Hum Hered 2007; 64: 97-106. (Pubitemid 46788219)
38. Kirov G, Ivanov D, Williams NM, Preece A, Nikolov I, Milev R et al. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol Psychiatry 2004; 55: 971-975. (Pubitemid 38581911)
39. Riley B, Kuo PH, Maher BS, Fanous AH, Sun J, Wormley B et al. The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample. Schizophr Res 2009; 115: 245-253.
40. Williams NM, Preece A, Morris DW, Spurlock G, Bray NJ, Stephens M et al. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch Gen Psychiatry 2004; 61: 336-344. (Pubitemid 38451542)
41. Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, Albus M et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 2003; 72: 185-190. (Pubitemid 36056855)
42. Ghiani CA, Starcevic M, Rodriguez-Fernandez IA, Nazarian R, Cheli VT, Chan LN et al. The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowth. Mol Psychiatry 2010; 15: 115, 204-15.
43. Iizuka Y, Sei Y, Weinberger DR, Straub RE. Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization. J Neurosci 2007; 27: 12390-12395. (Pubitemid 350085456)
44. Morris DW, Murphy K, Kenny N, Purcell SM, McGhee KA, Schwaiger S et al. Dysbindin (DTNBP1) and the biogenesis of lysosome-related organelles complex 1 (BLOC-1): main and epistatic gene effects are potential contributors to schizophrenia susceptibility. Biol Psychiatry 2008; 63: 24-31. (Pubitemid 350234879)
45. Guo AY, Sun J, Riley BP, Thiselton DL, Kendler KS, Zhao Z. The dystrobrevin-binding protein 1 gene: features and networks. Mol Psychiatry 2009; 14: 18-29.
46. Molteni R, Calabrese F, Racagni G, Fumagalli F, Riva MA. Antipsychotic drug actions on gene modulation and signaling mechanisms. Pharmacol Ther 2009; 124: 74-85.
47. Siuciak JA. The role of phosphodiesterases in schizophrenia: therapeutic implications. CNS Drugs 2008; 22: 983-993.
48. Chen X, Wang X, Hossain S, O'Neill FA, Walsh D, Pless L et al. Haplotypes spanning SPEC2, PDZ-G EF2 and ACSL6 genes are associated with schizophrenia. Hum Mol Genet 2006; 15: 3329-3342. (Pubitemid 44642624)
49. Chowdari KV, Mirnics K, Semwal P, Wood J, Lawrence E, Bhatia T et al. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 2002; 11: 1373-1380.
50. Schwab SG, Hoefgen B, Hanses C, Hassenbach MB, Albus M, Lerer B et al. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol Psychiatry 2005; 58: 446-450. (Pubitemid 41393606)
51. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001; 98: 6917-6922. (Pubitemid 32538317)
52. Olsen L, Hansen T, Jakobsen KD, Djurovic S, Melle I, Agartz I et al. The estrogen hypothesis of schizophrenia implicates glucose metabolism: association study in three independent samples. BMC Med Genet 2008; 9: 39.
53. Kahler AK, Djurovic S, Kulle B, Jonsson EG, Agartz I, Hall H et al. Association analysis of schizophrenia on 18 genes involved in neuronal migration: MDGA1 as a new susceptibility gene. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 1089-1100.
54. Shifman S, Johannesson M, Bronstein M, Chen SX, Collier DA, Craddock NJ et al. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet 2008; 4: e28.